← Evidence map

ArticleOsteoarthritis and cartilage open2022

Time to first and sustained improvement in WOMAC domains among patients with osteoarthritis receiving tanezumab.

D J Hunter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2022
2023
this papercites it

3 trials

Full record →Abstract, authors, funding and every citing paper · PMID 36474952